CommercialCoverageHigh impact
Autotransfusers and Red Blood Cell Genotyping (CPB 0639, reviewed 2025-12-11)
Aetna·Cardiothoracic Surgery, General Surgery, Orthopedics +6 more·Medical Policy
Effective date
Dec 11, 2025
We identified it
Aug 12, 2026
Summary
Aetna's Policy 0639 (effective 2025-12-11) establishes medical necessity criteria for autotransfusion/cell saver devices and red blood cell genotyping. Autotransfusers are covered only for high-blood-loss procedures (≥2 units), emergency/intra-operative salvage, or post-operative collection. Red cell genotyping is covered for transfusion-dependent hemolytic conditions, post-transfusion hemolysis, autoimmune hemolytic anemia, and fetal hemolytic disease management. All other uses are considered experimental.
Action Required
By December 11, 2025: (1) Billing team must implement utilization review logic in billing system to require prior authorization for CPT 86890 and 86891 (autotransfusion collection/salvage) only when procedure is documented to involve ≥2 units of blood loss or matches high-risk categories (cardiac surgery, organ transplant, vascular surgery, orthopedic procedures, emergency hemorrhage). (2) Update claim adjudication rules to DENY autotransfusion claims for procedures expected to require <2 units without clinical documentation justifying exception. (3) For red cell genotyping (CPT 0180U-0194U, 0196U), implement automated verification that claims include diagnosis codes from covered categories: D56.0-D56.9 (thalassemia), D57.00-D57.819 (sickle cell), D58.0-D58.9 (hereditary hemolytic anemia), or documentation of post-transfusion hemolysis/autoimmune hemolytic anemia/multiply transfused status/DAT positive status/fetal hemolytic disease/conflicting serology. (4) Flag claims for hypoxic RBC transfusions (HCPCS P9027 when used experimentally) for denial unless prior authorization explicitly approved. (5) Providers must document indication and blood loss estimate on operative reports; front desk should prompt providers during encounter setup for cardiac, orthopedic, and trauma cases. (6) Consequences: Claims lacking proper medical necessity documentation or diagnosis codes will be denied; autotransfusion devices billed for low-blood-loss procedures will be rejected.